Guest Commentary

Guest Commentary

The Present and Future Multiple Myeloma Landscape

Thursday, October 1st, 2015
The rapid pace of drug approvals in multiple myeloma (MM) shows no sign of abating. In the past two years, the U.S. Food and...
Advertisement

Current Issue

March 2017, Volume 3, Issue 4

This issue takes a look at diversity in the medical education system, provides a hematology drug pipeline update, and more.